[refurb]

This is actually a relevant point. Both Qnexa and Belviq were only recently approved. The companies who got them approved are pretty small and don't have the backing of a massive pharma company to help them with marketing.

In fact, the maker of Qnexa, Vivus, has had 3 CEOs over the past year and they are getting a lot of flack from shareholders over not putting in enough effort to market the drug.